R. M. K. Omar, A. M. Najar, E. Bobtaina, and A. F. Elsheikh, “Pryazolylpyridine and Triazolylpyridine derivative of hydroxychloroquine as Potential Therapeutic against COVID-19: Theoretical Evaluation”, J. Drug Delivery Ther., vol. 10, no. 4-s, pp. 181–186, Aug. 2020, doi: 10.22270/jddt.v10i4-s.4298.